Abstract:To assess the prognostic value of DNA ploidy in colorectal cancer, compared with the histopathological findings, paraffin-embedded surgical specimens from 330 patients who underwent resection for primary adenocarcinoma were studied using a new modified method of flow cytometry. Of these specimens, 141 were DNA diploid and 189, DNA aneuploid, among which there were 3 DNA hypodiploid lesions. Of the ten variables studied in curative resection, DNA ploidy ranked fourth in prognostic significance according to the … Show more
“…Furthermore, quantification of FISH signals has become a routine in predictive molecular pathology like HER2 analysis. In general, the frequency of aneuploid and near triploid cases of our FISH study is comparable with published DNA cytometry data [8,21,27]. In particular, our recent DNA ploidy analysis confirmed the presence of hypodiploid colon tumors and pointed to a putative relevance of hypodiploidy in the transition from adenomas to carcinomas [21].…”
Section: Discussionsupporting
confidence: 91%
“…The ploidy status of tumors is usually determined by DNA measurement using either flow cytometry or static DNA image analysis [8,21,27]. FISH represents an interesting alternative method because it is widely used in the diagnostic setup of many pathological institutes.…”
“…Furthermore, quantification of FISH signals has become a routine in predictive molecular pathology like HER2 analysis. In general, the frequency of aneuploid and near triploid cases of our FISH study is comparable with published DNA cytometry data [8,21,27]. In particular, our recent DNA ploidy analysis confirmed the presence of hypodiploid colon tumors and pointed to a putative relevance of hypodiploidy in the transition from adenomas to carcinomas [21].…”
Section: Discussionsupporting
confidence: 91%
“…The ploidy status of tumors is usually determined by DNA measurement using either flow cytometry or static DNA image analysis [8,21,27]. FISH represents an interesting alternative method because it is widely used in the diagnostic setup of many pathological institutes.…”
“…Generally, a more detailed assessment—for example, using array comparative genomic hybridisation (arrayCGH)—is impractical for large series. Nonetheless, many studies have reported that CIN+ measured by flow cytometry confers a worse prognosis; however, this observation is neither universal5 6 nor always significant 7 – 9. Consequently, it has been argued consistently that measuring CIN does not add further prognostic information to standard pathological and histological staging 10 – 13.…”
CIN is associated with a worse prognosis in CRC, and should be evaluated as a prognostic marker, together with MSI status, in all clinical trials, particularly those involving adjuvant therapies.
“…There were 12 studies which performed a multivariate analysis for OS. Out of these, six described statistical significance for aneuploidy [14,15,63,71,38,41]. For RFS, five studies performed multivariate analysis and two revealed statistical significance for the ploidy status [14,40].…”
Section: Flow Cytometrymentioning
confidence: 96%
“…Twenty-two studies tested for differences and/or correlations between aneuploidy rates and tumor stages. Out of these, eight studies (36.4 %) described statistical significance [17,18,42,54,56,58,43,41]. This particular aspect was focused on in our meta-analysis.…”
Section: Meta-analysis Of Aneuploidy Rate With Regard To Tumor Stagementioning
A substantial number of studies showed a prognostic importance of aneuploidy in CRC. Furthermore, the higher frequency of aneuploidy in late-stage CRC implies an increase in genomic instability with CRC progression, indicating aneuploidy to be also a stage-specific prognostic marker.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.